107 related articles for article (PubMed ID: 14660504)
1. Effects of estrogen and progesterone administration on extracellular fluid.
Stachenfeld NS; Taylor HS
J Appl Physiol (1985); 2004 Mar; 96(3):1011-8. PubMed ID: 14660504
[TBL] [Abstract][Full Text] [Related]
2. Exogenous oestradiol and progesterone administration does not cause oedema in healthy young women.
Stachenfeld NS; Taylor HS
Clin Endocrinol (Oxf); 2007 Mar; 66(3):410-8. PubMed ID: 17302877
[TBL] [Abstract][Full Text] [Related]
3. Progesterone increases plasma volume independent of estradiol.
Stachenfeld NS; Taylor HS
J Appl Physiol (1985); 2005 Jun; 98(6):1991-7. PubMed ID: 15718411
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone effects on transcapillary fluid dynamics.
Stachenfeld NS; Keefe DL; Palter SF
Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1319-29. PubMed ID: 11557642
[TBL] [Abstract][Full Text] [Related]
5. Responses to a saline load in gonadotropin-releasing hormone antagonist-pretreated premenopausal women receiving progesterone or estradiol-progesterone therapy.
Stachenfeld NS; Keefe DL; Taylor HS
J Clin Endocrinol Metab; 2005 Jan; 90(1):386-94. PubMed ID: 15486051
[TBL] [Abstract][Full Text] [Related]
6. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
[TBL] [Abstract][Full Text] [Related]
7. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of a gonadotropin-releasing hormone agonist on the luteal synthesis of progesterone, estradiol receptors, and prolactin surges during early pregnancy.
Sridaran R; Ghose M; Mahesh VB
Endocrinology; 1988 Oct; 123(4):1740-6. PubMed ID: 3046924
[TBL] [Abstract][Full Text] [Related]
9. Abrogation by a potent gonadotropin-releasing hormone antagonist of the estrogen/progesterone-stimulated surge-like release of luteinizing hormone and follicle-stimulating hormone in postmenopausal women.
Kolp LA; Pavlou SN; Urban RJ; Rivier JC; Vale WW; Veldhuis JD
J Clin Endocrinol Metab; 1992 Oct; 75(4):993-7. PubMed ID: 1400893
[TBL] [Abstract][Full Text] [Related]
10. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of GnRH agonist, GnRH antagonist, and estrogen plus progesterone treatment on apoptosis related genes in rat ovary.
Saatli B; Kizildag S; Posaci C; Dogan E; Koyuncuoglu M; Ulukus EC; Atabey N
Fertil Steril; 2009 May; 91(5 Suppl):2006-11. PubMed ID: 18829022
[TBL] [Abstract][Full Text] [Related]
12. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol.
Fatemi HM; Camus M; Kolibianakis EM; Tournaye H; Papanikolaou EG; Donoso P; Devroey P
Fertil Steril; 2007 Mar; 87(3):504-8. PubMed ID: 17140572
[TBL] [Abstract][Full Text] [Related]
13. Administration of a gonadotropin-releasing hormone antagonist to mares at different times during the luteal phase of the estrous cycle.
Evans MJ; Alexander SL; Irvine CH; Kitson NE; Taylor TB
Anim Reprod Sci; 2011 Sep; 127(3-4):188-96. PubMed ID: 21889856
[TBL] [Abstract][Full Text] [Related]
14. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles.
Simon C; Oberyé J; Bellver J; Vidal C; Bosch E; Horcajadas JA; Murphy C; Adams S; Riesewijk A; Mannaerts B; Pellicer A
Hum Reprod; 2005 Dec; 20(12):3318-27. PubMed ID: 16085660
[TBL] [Abstract][Full Text] [Related]
15. [The programming of IVF cycles with antagonists].
Hugues JN
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S19-20. PubMed ID: 15643680
[TBL] [Abstract][Full Text] [Related]
16. Estrogen effects on osmotic regulation of AVP and fluid balance.
Stachenfeld NS; Keefe DL
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E711-21. PubMed ID: 12217888
[TBL] [Abstract][Full Text] [Related]
17. Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone.
Araki S; Chikazawa K; Motoyama M; Ijima K; Abe N; Tamada T
J Clin Endocrinol Metab; 1985 Mar; 60(3):590-8. PubMed ID: 3919050
[TBL] [Abstract][Full Text] [Related]
18. [Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists].
Olivennes F
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S24-6. PubMed ID: 15643682
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome.
Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
BJOG; 2014 Jun; 121(7):848-55. PubMed ID: 24621101
[TBL] [Abstract][Full Text] [Related]
20. Sex hormone effects on body fluid and sodium regulation in women with and without exercise-associated hyponatremia.
Stachenfeld NS; Taylor HS
J Appl Physiol (1985); 2009 Sep; 107(3):864-72. PubMed ID: 19556454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
